Supplementary Figure 9 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Jian Ye,Weihua Guo,Chongkai Wang,Colt A. Egelston,Massimo D'Apuzzo,Geereesh Shankar,Marwan G. Fakih,Peter P. Lee

DOI: https://doi.org/10.1158/2767-9764.24298823

2023-01-01

Abstract:Progressive maturation of TLS in CRC primary tumor.

What problem does this paper attempt to address?

Supplementary Figure 10 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Jian Ye,Weihua Guo,Chongkai Wang,Colt A. Egelston,Massimo D’Apuzzo,Ganesh M. Shankar,Marwan Fakih,Peter P. Lee

DOI: https://doi.org/10.1158/2767-9764.24298853.v1

2023-01-01

Abstract:Distribution of LA and TLS across colorectal cancer sites.
Supplementary Figure 3 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Jian Ye,Weihua Guo,Chongkai Wang,Colt A. Egelston,Massimo D'Apuzzo,Geereesh Shankar,Marwan G. Fakih,Peter P. Lee

DOI: https://doi.org/10.1158/2767-9764.24298841

2023-01-01

Abstract:Distribution of immune cells in the cancer island and stroma of metastatic CRC TME.
Supplementary Figure 11 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Jian Ye,Weihua Guo,Chongkai Wang,Colt A. Egelston,Massimo D'Apuzzo,Geereesh Shankar,Marwan G. Fakih,Peter P. Lee

DOI: https://doi.org/10.1158/2767-9764.24298850.v1

2023-01-01

Abstract:Analysis of immune cells between paired primary and liver metastases.
Clinical Significance of Tertiary Lymphoid Structure Maturity in Colorectal Cancer Patients

Jiangjiang Zheng,Jingjing Yu,Jingjing Xie,Dong Chen,Hong Deng

DOI: https://doi.org/10.3724/zdxbyxb-2024-0320

2024-01-01

Abstract:OBJECTIVES:To explore the clinical significance of the maturation of tertiary lymphoid structures (TLS) in colorectal cancer patients. METHODS:A total of 230 surgical removed colorectal cancer specimens with detailed follow-up data were collected from Yinzhou Second Hospital. There were 128 cases of mature TLS and 108 cases of immature TLS according to immunohistochemical results. The patient age, gender, maximum tumor diameter, tumor location, differentiation degree, depth of invasion, lymph node metastasis, vascular tumor thrombus, liver metastasis, distant non-liver metastasis, mismatch repair status, expression of Ki-67, P53 and programmed cell death ligand 1 (PD-L1) were analyzed. The Kaplan-Meier method (Breslow test) was used to analyze the survival of patients, and multivariate Cox regression model was applied to analyze the prognostic factors. RESULTS:Compared to the immature TLS group, the mature TLS group showed a significantly lower rate of vascular tumor thrombus, lymph node metastasis, and liver metastasis. Additionally, the positive expression rate of Ki-67 was markedly reduced, while the rate of deficient mismatch repair and the positive expression rate of PD-L1 were significantly increased (all P<0.05). The overall survival rate of the mature TLS group was superior to that of the immature TLS group (Breslow=4.553, P<0.05). Cox regression analysis indicated that lymph node metastasis was an independent risk factor for the prognosis of colorectal cancer patients (P<0.01), while TLS maturation was a protective factor (P<0.05). CONCLUSIONS:The formation of TLS may play a significant role in inhibiting lymph node metastasis, liver metastasis, and vascular tumor thrombus in colorectal cancer, and patients with mature TLS have a favorable clinical prognosis, which can provide a reference for the immunotherapy and prognostic assessment of colorectal cancer patients.
Supplementary Table 1 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Jian Ye,Weihua Guo,Chongkai Wang,Colt A. Egelston,Massimo D'Apuzzo,Geereesh Shankar,Marwan G. Fakih,Peter P. Lee

DOI: https://doi.org/10.1158/2767-9764.24298820.v1

2023-01-01

Abstract:Detailed summary of CRC specimens and patient overall survival.
Supplementary Figure 12 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Jian Ye,Weihua Guo,Chongkai Wang,Colt A. Egelston,Massimo D'Apuzzo,Geereesh Shankar,Marwan G. Fakih,Peter P. Lee

DOI: https://doi.org/10.1158/2767-9764.24298847

2023-01-01

Abstract:Clustered heatmap of relative expression of proteins (GeoMX DSP) per ROI from CRCmetastatic tumor specimens (5 tumors/metastatic site).
Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Sonia A. Patel,Monique B. Nilsson,Yan Yang,Xiuning Le,Hai T. Tran,Yasir Y. Elamin,Xiaoxing Yu,Fahao Zhang,Alissa Poteete,Xiaoyang Ren,Li Shen,Jing Wang,Seyed Javad Moghaddam,Tina Cascone,Michael Curran,Don L. Gibbons,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22494757.v1

2023-01-01

Abstract:EGFR-mutant NSCLC EGFR-independent tumor model is refractory to EGFR-TKI treatment.
FIGURE 4 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Jian Ye,Weihua Guo,Chongkai Wang,Colt A. Egelston,Massimo D’Apuzzo,Ganesh M. Shankar,Marwan Fakih,Peter P. Lee

DOI: https://doi.org/10.1158/2767-9764.24298871

2023-01-01

Abstract:Higher antigen presentation potential in lung metastases. A, Correlations of the immune cell density between histologic regions. PCC were calculated from the density of each immune cell type in different histologic regions. B, Representative images of primary and metastatic colorectal cancer tumors stained with mIF panel 4. The cancer cells, TCF1+ CD4 T cells, stem-like CD8 T cells and APCs were color coded and identified as Fig. 1C. The yellow dash lines indicate the boundaries between inner and outer invasive margin. C, Mean number of TCF1+ CD4 T cells and stem-like CD8 T cells around 10 µm radius of APCs and mean number of APCs around 10 µm radius of TCF1+ CD4 T cells and stem-like CD8 T cells. D, Paired comparison of cell density between each two organs in the different histologic regions. Statistical significance was determined by Wilcoxon signed-rank test. E, GSEA of liver and lung metastases samples from GES48468. Kyoto Encyclopedia of Genes and Genomes (KEGG) databases were used to determine significantly modified pathways. Bars in red and blue represent, respectively, a positive and negative enrichment in the associated pathway. The x axis shows the normalized enrichment score (NES) of the analysis, and the y axis the enriched pathways. F, Heat map of top genes differentially expressed in GES48468 primary and metastatic colorectal cancer tumor samples from KEGG_ANITGENE_PROCESSING_AND_PRESENTATION pathway.
Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Jian Ye,Weihua Guo,Chongkai Wang,Colt A Egelston,Massimo D'Apuzzo,Geereesh Shankar,Marwan G Fakih,Peter P Lee

DOI: https://doi.org/10.1158/2767-9764.CRC-23-0212

2023-10-12

Abstract:Patients with microsatellite stable (MSS) colorectal cancer with liver metastases are resistant to immune checkpoint inhibitor (ICI) therapy, while about one-third of patients with colorectal cancer without liver metastases, particularly those with lung-only metastases, respond to ICI. We analyzed primary colorectal cancer tumors and major metastatic sites (liver, lung, peritoneal) using multiplex immunofluorescence and whole-slide spatial analyses to identify variations in immune contexture and regional localization within the tumor microenvironment. While levels of T and B cells within peritumoral regions were similar, their levels were significantly lower within the tumor core of liver and peritoneal metastases compared with lung metastases. In contrast, antigen-presenting cells (APC) and APC-T cell interactions were more abundant in all regions of lung metastases. We also identified an abundance of lymphoid aggregates throughout lung metastases, but these were present only within peritumoral regions of liver and peritoneal metastases. Larger lymphoid aggregates consistent with features of tertiary lymphoid structures were observed within or adjacent to primary tumors, but not metastatic lesions. Our findings were validated using NanoString GeoMx DSP, which further showed that liver metastases had higher expression of immune-suppressive markers, while lung metastases showed higher proinflammatory activity and T-cell activation markers. Peritoneal metastases demonstrated higher expression of cancer-associated fibroblast-related proteins and upregulated PD-1/PD-L1 signaling molecules. Our results demonstrate that functional status and spatial distribution of immune cells vary significantly across different metastatic sites. These findings suggest that metastatic site-dependent immune contexture may underlie discordant responses to ICI therapy in patients with MSS colorectal cancer. Significance: Our results demonstrate that functional status and spatial distribution of immune cells vary significantly across different metastatic sites in MSS colorectal cancer. These findings suggest that metastatic site-dependent immune contexture may underlie discordant responses to ICI therapy in patients with MSS colorectal cancer.
Supplementary Table S3 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Yingcheng Wu,Shuaixi Yang,Jiaqiang Ma,Zechuan Chen,Guohe Song,Dongning Rao,Yifei Cheng,Siyuan Huang,Yifei Liu,Shan Jiang,Jinxia Liu,Xiaowu Huang,Xiaoying Wang,Shuangjian Qiu,Jianmin Xu,Ruibin Xi,Fan Bai,Jian Zhou,Jia Fan,Xiaoming Zhang,Qiang Gao

DOI: https://doi.org/10.1158/2159-8290.22540408

2023-01-01

Abstract:Supplementary Table S3. Differentially expressed genes between LM and CRC infiltrated MRC1+ CCL18+ macrophages & SPP1+ macrophages.
Supplementary Figure 8 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530045.v1

2023-01-01

Abstract:Supplementary Figure 8 - PDF file 84K, Immune cell profiling and IFN-gamma production in CD8 T cells in tumor tissues between Tgfbr2flox/flox and Tgfbr2MyeKO mice bearing 4T1 tumors
Supplementary Figure S6 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407845

2023-01-01

Abstract:Fold increase in myeloid cell subsets in the lungs.
Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384260.v1

2023-01-01

Abstract:Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384257

2023-01-01

Abstract:Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figure 6 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384251

2023-01-01

Abstract:Supplementary Figure 6 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Cellular and molecular mechanisms regulating the development of tertiary lymphoid structures in tumor

Anthony B. Rodriguez,J David Peske,Amber N. Woods,Marit Martina Melssen,Salwador Cyranowski,Geoffrey Raymond Parriott,Victor H. Engelhard

DOI: https://doi.org/10.4049/jimmunol.200.supp.178.10

2018-05-01

The Journal of Immunology

Abstract:Abstract Tertiary lymphoid structures (TLS) have been described in association with several tumor types, and they are usually associated with enhanced patient survival. However, mechanisms regulating their formation remain unknown. We found that intra- and peri-tumoral TLS develop in intraperitoneal (IP) but not subcutaneously (SC) implanted tumors. These TLS are characterized by a robust accumulation of B cells, and an associated reticular network of podoplanin+ fibroblasts expressing high levels of CXCL12, CXCL13, and the B-cell survival factors BAFF and APRIL. These results suggest that IP tumor-associated fibroblasts are polarized into organizer cells that orchestrate TLS formation. We’ve previously demonstrated that CD8 T effectors induce the development of lymph node-like vasculature in IP tumors. To determine whether these cells also regulate TLS development, we evaluated IP tumors grown in Rag1−/− mice and Rag1−/− mice repleted with bulk CD8 T cells. CD8 T cells upregulated the number of podoplanin+ fibroblasts and CXCL12 expression. However, CXCL13, BAFF and APRIL expression was not dependent on CD8 T cells. Thus, the representation of podoplanin+ fibroblasts and their expression of CXCL12 is regulated by adaptive immunity, while their expression of CXCL13, BAFF and APRIL is mediated by an innate element within the IP tumor microenvironment. We also found that increasing the load of the model tumor antigen ovalbumin led to an increased formation of peri-tumoral TLS with a classical organization, on top of the non-classical intratumoral structures evident at a low antigen load. These results identify novel mechanisms regulating different elements involved in organizing tumor-associated TLS.

immunology
Supplementary Figure 5 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384254

2023-01-01

Abstract:Supplementary Figure 5 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figure 7 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384248

2023-01-01

Abstract:Supplementary Figure 7 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer

Miao He,Qihua He,Xiuyu Cai,Jun Liu,Hongshen Deng,Feng Li,Ran Zhong,Yi Lu,Haoxin Peng,Xiangrong Wu,Zisheng Chen,Shen Lao,Caichen Li,Jianfu Li,Jianxing He,Wenhua Liang

DOI: https://doi.org/10.1136/jitc-2022-005539

IF: 12.469

2023-04-01

Journal for ImmunoTherapy of Cancer

Abstract:Background Tertiary lymphoid structure (TLS) is an organized infiltration of immune cells, showing features of germinal center (GC) commonly seen in secondary lymphoid organs. However, its relationship with tumor-draining lymph nodes (TDLNs) has not been studied and we hypothesized that TDLN may influence maturation of intratumoral TLS in non-small cell lung cancer (NSCLC). Methods Tissue slides of 616 patients that had undergone surgeries were examined. Cox proportional hazard regression model was used to assess risk factors of patients’ survival, and logistic regression model was used for their relationship with TLS. Single-cell RNA-sequencing (scRNA-seq) was employed to explore transcriptomic features of TDLNs. Immunohistochemistry, multiplex immunofluorescence and flow cytometry were performed to analyze cellular composition. Cellular components of NSCLC samples from The Cancer Genome Atlas database were inferred with Microenvironment Cell Populations-counter (MCP-counter) method. Murine NSCLC models were used to dissect underlying mechanisms for relationship between TDLN and TLS maturation. Results While GC + TLS was associated with better prognosis, GC − TLS was not. TDLN metastasis reduced the prognostic relevance of TLS, and was associated with less GC formation. Primary tumor sites showed reduced B cell infiltration in TDLN-positive patients, and scRNA-seq revealed diminished memory B cell formation in tumor-invaded TDLNs, together with an emphasis on weakened interferon (IFN)-γ response. Murine NSCLC models revealed that IFN-γ signaling is involved in memory B cell differentiation in TDLNs and GC formation in primary tumors. Conclusions Our research emphasizes the influence of TDLN on intratumoral TLS maturation and suggests a role of memory B cells and IFN-γ signaling in this communication.

oncology,immunology
Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384266

2023-01-01

Abstract:Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 9 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Supplementary Figure 10 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Supplementary Figure 3 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Supplementary Figure 11 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Clinical Significance of Tertiary Lymphoid Structure Maturity in Colorectal Cancer Patients

Supplementary Table 1 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Supplementary Figure 12 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

FIGURE 4 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Supplementary Table S3 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Supplementary Figure 8 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure S6 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 6 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Cellular and molecular mechanisms regulating the development of tertiary lymphoid structures in tumor

Supplementary Figure 5 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 7 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer

Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 9 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Supplementary Figure 10 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Supplementary Figure 3 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Supplementary Figure 11 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Clinical Significance of Tertiary Lymphoid Structure Maturity in Colorectal Cancer Patients

Supplementary Table 1 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Supplementary Figure 12 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

FIGURE 4 from Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver Versus Lung Metastases

Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Supplementary Table S3 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Supplementary Figure 8 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure S6 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 6 from Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Cellular and molecular mechanisms regulating the development of tertiary lymphoid structures in tumor

Supplementary Figure 5 from Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 7 from Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer

Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 6 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 5 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 7 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts